Annual Drug Patent Expirations for ARMONAIR+RESPICLICK Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are seventeen…
The post New patent for Teva Pharm drug ARMONAIR RESPICLICK …
New patent for Teva Pharm drug ARMONAIR RESPICLICK Read Post »
Annual Drug Patent Expirations for ARMONAIR+DIGIHALER Armonair Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are twenty…
The post New patent for Teva Pharm drug ARMONAIR DIGIHALER appear…
New patent for Teva Pharm drug ARMONAIR DIGIHALER Read Post »
Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from one supplier. There are…
The post New patent for Teva Branded drug PROAIR RESPICLICK appear…
New patent for Teva Branded drug PROAIR RESPICLICK Read Post »
Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from one supplier. There are…
The post New patent for Teva Branded drug PROAIR DIGIHALER appeared …
New patent for Teva Branded drug PROAIR DIGIHALER Read Post »
This chart shows the pharmaceutical companies with the most patents in European Patent Office. Patents must be filed in each country (or, in some cases regional patent office) where patent…
The post Which pharmaceutical companies have the most drug pat…
Which pharmaceutical companies have the most drug patents in European Patent Office? Read Post »
This chart shows the companies which have received the most pediatric exclusivities in the past five years. Pediatric exclusivity is granted to drug companies for conducting pediatric studies on their…
The post Pharmaceutical companies with the most ‘P…
Pharmaceutical companies with the most ‘Pediatric Exclusivity’ drugs Read Post »
Here is a copy of the talk I gave at the recent Marcusevans 13th Portfolio Management and Pipeline Optimization for Generics. I cover: How to find and evaluate generic entry…
The post Finding and Evaluating Generic Drug Market Entry Opportunities appea…
Finding and Evaluating Generic Drug Market Entry Opportunities Read Post »
This article not subject to U.S. Copyright. Published 2019 by the American Chemical Society. Noel T. Southall Abstract We report our experience working with the US Food and Drug Administration…
The post Freedom of Information Act Access to an Investiga…
Freedom of Information Act Access to an Investigational New Drug Application Read Post »
Annual Drug Patent Expirations for ANNOVERA Annovera is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent for Therapeuticsmd Inc drug ANNOVERA appeared first on…
Annual Drug Patent Expirations for DOJOLVI Dojolvi is a drug marketed by Ultragenyx Pharm Inc and is included in one NDA. It is available from one supplier. The generic ingredient…
The post New patent for Ultragenyx Pharm drug DOJOLVI appeared first on…
Get new actionable insights and updates from BiotechBlog
